Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

0
Player Avatar blackmonday2007 (< 20) Submitted: 9/15/2009 11:52:59 AM : Outperform Start Price: $19.59 EBS Score: -55.91

MIKE TURNER PICK

Featured Broker Partners


Advertisement